City Hall
1 Dr. Carlton B. Goodlett
Place
San Francisco, CA 94102-
4689
City and County of San Francisco
Legislation Details
File #:
Version:
1
211115
Name:
Closed Session - Existing Litigation -
AmerisourceBergen Corp., Cardinal Health, Inc.,
and McKesson Corp. - City to Receive up to $50
Million (File 211071) - Johnson & Johnson - City to
Receive up to $11 Million (File 211072)
Status:
Type:
Hearing
Filed
File created:
In control:
10/26/2021
Board of Supervisors
On agenda:
Final action:
11/2/2021
11/2/2021
Enactment date:
Enactment #:
Title:
Closed Session for the Board of Supervisors to convene on November 2, 2021, pursuant to California
Government Code, Section 54956.9, and San Francisco Administrative Code, Section 67.10(d)(1), for
the purpose of conferring with, or receiving advice from the City Attorney regarding existing litigation
relating to the partial settlement of the lawsuit filed on behalf of the City and County of San Francisco
and the People of the State of California against three large distributors of prescription opioids
(AmerisourceBergen Corporation, Cardinal Health, Inc., and McKesson Corporation) for abatement
funds in the range of $27 million to $50 million to be paid over 18 years, entitled The City and County
of San Francisco and the People of the State of California v. Purdue Pharma L.P., Richard S. Sackler,
Jonathan D. Sackler, Mortimer D.A. Sackler, Kathe A. Sackler, Ilene Sackler Lefcourt, Beverly Sackler,
Theresa Sackler, David A. Sackler, Trust for the Benefit of Members of the Raymond Sackler Family,
Rhodes Pharmaceuticals L.P., Cephalon, Inc., Teva Pharmaceutical Industries Ltd., Teva
Pharmaceuticals USA, Inc., Endo International Plc, Endo Health Solutions Inc., Endo Pharmaceuticals
Inc., Janssen Pharmaceuticals, Inc., Insys Therapeutics, Inc., Mallinckrodt Plc, Mallinckrodt LLC,
Allergan Plc F/K/A Actavis Plc, Watson Pharmaceuticals, Inc. N/K/A Actavis, Inc., Watson
Laboratories, Inc., Actavis LLC, Actavis Pharma, Inc. F/K/A/ Watson Pharma, Inc.,
AmerisourceBergen Corporation, Cardinal Health, Inc., and McKesson Corporation (File No. 211071);
and the partial settlement of the lawsuit filed on behalf of the City and County of San Francisco and
the People of the State of California against Johnson & Johnson and its subsidiary, Janssen
Pharmaceuticals, Inc., for abatement funds in the range of $6 million to $11 million to be paid over
nine years, entitled The City and County of San Francisco and the People of the State of California v.
Purdue Pharma L.P., Richard S. Sackler, Jonathan D. Sackler, Mortimer D.A. Sackler, Kathe A.
Sackler, Ilene Sackler Lefcourt, Beverly Sackler, Theresa Sackler, David A. Sackler, Trust for the
Benefit of Members of the Raymond Sackler Family, Rhodes Pharmaceuticals L.P., Cephalon, Inc.,
Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Endo International Plc, Endo
Health Solutions Inc., Endo Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc., Insys Therapeutics,
Inc., Mallinckrodt Plc, Mallinckrodt LLC, Allergan Plc F/K/A Actavis Plc, Watson Pharmaceuticals, Inc.
N/K/A Actavis, Inc., Watson Laboratories, Inc., Actavis LLC, Actavis Pharma, Inc. F/K/A/ Watson
Pharma, Inc., AmerisourceBergen Corporation, Cardinal Health, Inc., and McKesson Corporation (File
No. 211072); scheduled pursuant to Motion Nos. M21-148 (File No. 211112) and M21-149 (File No.
211114), approved on October 26, 2021.
Sponsors:
Attachments:
1. Board Pkt 110221
Action By
Date
Action
Result
Ver.
SCHEDULED FOR PUBLIC HEARING
Clerk of the Board
10/26/2021
1
HEARD IN CLOSED SESSION
Board of Supervisors
11/2/2021
1